Beacon Therapeutics
Amy Perniciaro is the Global VP of Clinical Operations at Beacon Therapeutics, with previous experience as a Clinical Operations Consultant and Vice President at various biotech and pharma companies. Amy has extensive experience leading clinical operations for global ophthalmology and rare disease gene therapy programs, as well as overseeing clinical trials in rare diseases such as nmDMD, Aniridia, and Dravet Syndrome. Amy has a BA in Biology & Psychology from Rutgers University.
This person is not in any offices
Beacon Therapeutics
2 followers
Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.